Overactive Bladder - Results from #200

REVIEW UroToday

Associations of Clinical and Dosimetric Parameters with Urinary Toxicities after Prostate Brachytherapy: A Long-Term Single-Institution Experience. September 3, 2023

Assessment of prescribing practices in overactive bladder pharmacotherapy across different specialties of India: a prescription trend analysis. August 27, 2023

Weak association between arterial hypertension and overactive bladder baseline symptoms and treatment responses. August 27, 2023

Intravesical Injection of Botulinum Toxin Type A in Patients with Refractory Overactive Bladder-Results between Young and Elderly Populations, and Factors Associated with Unfavorable Outcomes. August 27, 2023

Plain language summary of safety and symptom improvement with vibegron in people with overactive bladder: results from the EMPOWUR study. August 20, 2023

Age-related white matter hyperintensities and overactive bladder: A systematic review. August 20, 2023

Plain language summary: does treatment with vibegron result in improvements in overactive bladder (OAB) symptoms that are meaningful to people with OAB? August 20, 2023

Efficacy and Safety of Eliapixant in Overactive Bladder: The 12-Week, Randomised, Placebo-controlled Phase 2a OVADER Study. August 13, 2023

Urodynamic parameter improvements after mirabegron vs. antimuscarinics agents in non-neurogenic overactive bladder: a systematic review and meta-analysis of treatment effect. August 6, 2023

Predictive factors for postoperative medication therapy for overactive bladder symptoms after holmium laser enucleation of prostate. August 6, 2023

Predictive Factors for High Post-void Residual Volume in Older Females After OnabotulinumA Treatment for Severe Overactive Bladder Using a Machine Learning Model. August 6, 2023

Comparative assessment of efficacy and safety of approved oral therapies for overactive bladder: a systematic review and network meta-analysis. July 30, 2023

Factors Related to Overactive Bladder-like Symptoms in Bladder Cancer. July 30, 2023

Comparison Of Solifenacin And Mirabegron For The Treatment Of Overactive Bladder. July 23, 2023

Decrease in the Ratio proBDNF/BDNF in the Urine of Aging Female Patients with OAB. July 23, 2023

Transcutaneous medial plantar nerve stimulation in women with idiopathic overactive bladder. July 16, 2023

Sex and Gender Differences in the Pharmacology of the Overactive Urinary Bladder. July 16, 2023

A Randomized, Double-Blind, Placebo-Controlled, Bridging Study to Evaluate the Efficacy and Safety of Vibegron in Treating Korean Patients With Overactive Bladder. July 9, 2023

Persistence of overactive bladder pharmacological treatment in women as reflected from large-scale real-world data of prescription claims: A retrospective cohort study. July 9, 2023

Should the Preference-Based Index Set of Values be Country or Disease Specific? An Analysis Using Data From Women With Symptoms of Overactive Bladder. July 9, 2023

Page 11 of 121